• Bhang Inc. (BHNG) subsidiary, Red Ace Organics, has entered a partnership agreement with top US swimmers
  • The agreement will endorse the company’s products as the drink of choice among elite athletes
  • Red Ace Organics was purchased by Bhang Inc. in September 2019
  • Shares in the company are currently up 16.67% to $0.18, with a market cap of $8.93 million

Bhang Inc. (BHNG) has announced that its wholly owned subsidiary, Red Ace Organics, has entered a partnership agreement with US swimmers Ashley Twichell, Jacob Pebley and Tom Shields to endorse the company’s products as the drink of choice among top athletes.

Red Ace is a manufacturer of beetroot-based shot drinks that are rich in nitric oxide – a molecule which plays an important role in vasodilation.

“It is an honor to be chosen by the highest-performing athletes in the world as their beverage of choice for increased performance,” said Red Ace co-founder and President, William Leslie.

“Ashley, Jacob and Tom are very discerning as to what they put in their bodies, and the brand they trust is Red Ace. We know that is a great privilege.”

Established in 2011 by Mr. Leslie and Miles McCabe, Red Ace’s products are sold through over 1,400 distribution points, including Whole Foods Markets, Sprouts Farmers Markets and Amazon.

“I only associate myself with products I believe in,” said Tom Shields, who won gold at the 2016 Rio Olympics as part of the 4×100 medley relay.

“Red Ace Beet Performance is something I would buy, even if Red Ace weren’t my sponsor.”

With increased nitric oxide in the body, blood vessels are able to relax and allow more oxygen to pass through, improving brain activity and potentially lowering blood pressure.

“Our nutritionist told me to try Red Ace Beet Performance, and I immediately saw a difference in my recovery and overall performance. I recommend taking Red Ace daily,” said Jacob Pebley, four-time World Championship medallist.

Bhang Inc. acquired Red Ace Organics in September 2019.

Shares in the company are currently up 16.67% to $0.18, with a market cap of $8.93 million.

More From The Market Herald

The Market Herald’s Weekly Cannabis Report – Dec. 8, 2023

Investors in the cannabis industry have had their eyes on Canopy Growth stock, considering its potential for growth and profitability.

Buzz on the Bullboards: Who’s taking off and who’s grounded

As everyone races toward the finish line, let’s take a look at some of the stocks that are standing out from the rest.

Cannara reports record growth and profitability in Q4 2023

Cannabis producer Cannara Biotech Inc. (TSXV:LOVE) reported record growth and profitability in its Q4 and 2023 fiscal year results.

Will Canopy Growth stock recover?

Cannabis Investors have had their eyes on Canopy Growth (TSX:WEED) stock, considering its potential for growth and profitability.